JP2021530971A5 - - Google Patents
Info
- Publication number
- JP2021530971A5 JP2021530971A5 JP2020571816A JP2020571816A JP2021530971A5 JP 2021530971 A5 JP2021530971 A5 JP 2021530971A5 JP 2020571816 A JP2020571816 A JP 2020571816A JP 2020571816 A JP2020571816 A JP 2020571816A JP 2021530971 A5 JP2021530971 A5 JP 2021530971A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- her2
- tac
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862699173P | 2018-07-17 | 2018-07-17 | |
| US62/699,173 | 2018-07-17 | ||
| US201862703037P | 2018-07-25 | 2018-07-25 | |
| US62/703,037 | 2018-07-25 | ||
| US201862773120P | 2018-11-29 | 2018-11-29 | |
| US62/773,120 | 2018-11-29 | ||
| US201962826853P | 2019-03-29 | 2019-03-29 | |
| US62/826,853 | 2019-03-29 | ||
| US201962828879P | 2019-04-03 | 2019-04-03 | |
| US62/828,879 | 2019-04-03 | ||
| US201962839235P | 2019-04-26 | 2019-04-26 | |
| US62/839,235 | 2019-04-26 | ||
| US16/442,274 | 2019-06-14 | ||
| US16/442,274 US10640562B2 (en) | 2018-07-17 | 2019-06-14 | T cell-antigen coupler with various construct optimizations |
| US201962874426P | 2019-07-15 | 2019-07-15 | |
| US62/874,426 | 2019-07-15 | ||
| PCT/US2019/042297 WO2020018727A1 (en) | 2018-07-17 | 2019-07-17 | T cell-antigen coupler with various construct optimizations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530971A JP2021530971A (ja) | 2021-11-18 |
| JP2021530971A5 true JP2021530971A5 (enExample) | 2022-07-14 |
| JP7404279B2 JP7404279B2 (ja) | 2023-12-25 |
Family
ID=69163917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571816A Active JP7404279B2 (ja) | 2018-07-17 | 2019-07-17 | 様々な構築物最適化を備えたｔ細胞抗原カプラ |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3823984A4 (enExample) |
| JP (1) | JP7404279B2 (enExample) |
| KR (1) | KR102834084B1 (enExample) |
| CN (1) | CN112689642B (enExample) |
| AU (1) | AU2019307905B2 (enExample) |
| BR (1) | BR112021000735A2 (enExample) |
| CA (1) | CA3104887A1 (enExample) |
| IL (1) | IL280049A (enExample) |
| MX (1) | MX2021000541A (enExample) |
| PH (1) | PH12021550114A1 (enExample) |
| SG (1) | SG11202100307WA (enExample) |
| WO (1) | WO2020018727A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016018100A2 (pt) | 2014-02-07 | 2018-02-20 | Univ Mcmaster | acoplador antigênico de células t trifuncional, métodos e usos do mesmo |
| CN111479925B (zh) | 2017-10-12 | 2024-03-08 | 麦克马斯特大学 | 具有y182t突变的t细胞-抗原偶联物及其方法和用途 |
| US11110123B2 (en) | 2018-07-17 | 2021-09-07 | Triumvira Immunologics Usa, Inc. | T cell-antigen coupler with various construct optimizations |
| US10640562B2 (en) | 2018-07-17 | 2020-05-05 | Mcmaster University | T cell-antigen coupler with various construct optimizations |
| WO2022226065A2 (en) | 2021-04-21 | 2022-10-27 | Conagen Inc. | Biosynthetic production of delta-lactones using cytochrome p450 hydroxylase enzymes or mutants thereof |
| AU2022283819A1 (en) | 2021-06-01 | 2024-01-04 | Triumvira Immunologics Usa, Inc. | Claudin 18.2 t cell-antigen couplers and uses thereof |
| US11453723B1 (en) | 2021-06-25 | 2022-09-27 | Mcmaster University | BCMA T cell-antigen couplers and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE033245T2 (hu) * | 2011-12-19 | 2017-11-28 | Synimmune Gmbh | Bispecifikus ellenanyag molekula |
| JP2015524255A (ja) * | 2012-07-13 | 2015-08-24 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 二重特異性抗体を共導入することによってｃａｒｔ細胞の活性を強化する方法 |
| BR112016018100A2 (pt) * | 2014-02-07 | 2018-02-20 | Univ Mcmaster | acoplador antigênico de células t trifuncional, métodos e usos do mesmo |
| JP6961490B2 (ja) * | 2015-04-08 | 2021-11-05 | ノバルティス アーゲー | Ｃｄ２０療法、ｃｄ２２療法、およびｃｄ１９キメラ抗原受容体（ｃａｒ）発現細胞との併用療法 |
| WO2016166139A1 (en) | 2015-04-14 | 2016-10-20 | Eberhard Karls Universität Tübingen | Bispecific fusion proteins for enhancing immune responses of lymphocytes against tumor cells |
| CA3030003A1 (en) * | 2016-07-08 | 2018-01-11 | F1 Oncology, Inc. | Methods and compositions for transducing lymphocytes and regulating the activity thereof |
| CA3032838A1 (en) | 2016-08-04 | 2018-02-08 | Memorial Sloan-Kettering Cancer Center | Compositions and methods for immunotherapy |
| CN108250302A (zh) * | 2016-12-29 | 2018-07-06 | 天津天锐生物科技有限公司 | 一种多功能蛋白质 |
-
2019
- 2019-07-17 JP JP2020571816A patent/JP7404279B2/ja active Active
- 2019-07-17 AU AU2019307905A patent/AU2019307905B2/en active Active
- 2019-07-17 EP EP19838648.4A patent/EP3823984A4/en active Pending
- 2019-07-17 CA CA3104887A patent/CA3104887A1/en active Pending
- 2019-07-17 BR BR112021000735-0A patent/BR112021000735A2/pt unknown
- 2019-07-17 SG SG11202100307WA patent/SG11202100307WA/en unknown
- 2019-07-17 CN CN201980047935.6A patent/CN112689642B/zh active Active
- 2019-07-17 KR KR1020217004572A patent/KR102834084B1/ko active Active
- 2019-07-17 MX MX2021000541A patent/MX2021000541A/es unknown
- 2019-07-17 WO PCT/US2019/042297 patent/WO2020018727A1/en not_active Ceased
-
2021
- 2021-01-10 IL IL280049A patent/IL280049A/en unknown
- 2021-01-15 PH PH12021550114A patent/PH12021550114A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530971A5 (enExample) | ||
| JP2022017333A5 (enExample) | ||
| JP2024522357A5 (enExample) | ||
| FI3599251T3 (fi) | Cd20-antigeeniin kohdentuvan kimeerisen antigeenireseptorin rakentaminen ja sillä muunnettujen t-solujen aktiivisuuden tunnistaminen | |
| IL259120A (en) | Her2-targeted antigen chimeric receptors2 | |
| JP2008056679A5 (enExample) | ||
| RU2020127887A (ru) | Полипептиды транспозазы и их применение | |
| JP2017160222A5 (enExample) | ||
| JP2020517635A5 (enExample) | ||
| MY203553A (en) | Novel engineered t cell receptors and immune therapy using the same | |
| JP2020500523A5 (enExample) | ||
| JP2017523184A5 (enExample) | ||
| JP2013513377A5 (enExample) | ||
| RU2021130306A (ru) | Композиции il-12, нацеленные на edb | |
| RU2016146389A (ru) | Улучшенные полиэтилениминовые полиэтиленгликолевые векторы | |
| CN114592010A (zh) | NK-CAR-MbIL-15细胞及其制备方法和应用 | |
| JP2022512538A5 (enExample) | ||
| WO2017041739A1 (zh) | 改造的白介素12及其在制备治疗肿瘤药物中的用途 | |
| CN115232217B (zh) | 一种SynNotch结构及其应用 | |
| WO2015172563A1 (zh) | 一种靶向eps8与egfr结合的短肽及其应用 | |
| Wang et al. | Placental targeted drug delivery: a review of recent progress | |
| Aljabali et al. | The dual promise of oncolytic viruses: selective targeting and therapeutic enhancement in cancer treatment | |
| JP2021505190A5 (enExample) | ||
| MX2025015364A (es) | Proteinas de union al antigeno contra el peptido antigenico b2 asociado al melanoma expresado en tumores (mageb2) | |
| RU2020100072A (ru) | Иммуногенные композиции, содержащие cea, muc1 и tert |